Research and Economic Development

JSU Sponsored Research

COVID-19 Update


In light of the COVID-19 pandemic, the Office of Research and Economic Development is providing the following information to support the continuity of research (to the extent possible). This information is complementary to the information provided by Jackson State University’s COVID-19 update website ( Researchers should remain up to date on relevant information, by frequently visiting this website. This site is a living document updating current events that impact the JSU campus.

Due to the uncertainty about when we will return to normalcy, this information below is provided to assist researchers in navigating their research and sponsored programs responsibilities. The information will be updated periodically. Research sponsors are also providing information in the form of FAQs. We will post those FAQs here as we receive them.


Center for Disease Control and Prevention (CDC)

CDC’s Updated Considerations for Institutions of Higher Learning

The CDC emphasizes that “these considerations are meant to supplement—not replace—any state, local, territorial, or tribal health and safety laws, rules, and regulations with which IHEs must comply.

National Science Foundation

NSF Implementation of OMB Memorandum M-20-17, entitled, “Administrative Relief for Recipients and Applicants of Federal Financial Assistance Directly Impacted by the Novel Coronavirus (COVID-19) due to Loss of Operations” dated March 19, 2020

Go to, noting in particular that “All NSF awards are eligible for one-year grantee-approved no-cost extensions and then further extensions as approved by NSF. If you foresee a need for NSF-approved extensions, you should include that information in your annual report and discuss the need ahead of time with the cognizant NSF program officer for your award. See the Proposal & Award Policies & Procedures Guide (PAPPG), Chapter VI.D.3, for additional information.”

NSF Guidance for Research Community
Statement on Coronavirus Disease 2019 (COVID-19)
Includes impact on NSF’s acceptance and review of proposals, impact on award oversight, impact on meetings funded via a grant from NSF, etc.

NSF Financial Management and Record Retention Requirements

During these challenging times, it is critical that you maintain appropriate cost documentation and records as required by 2 CFR 200.302, “Financial Management and 2 CFR 200.333, Retention Requirements for Records.”

  • A special circumstance that we are facing is the appropriation of supplemental NSF funds under the Coronavirus Aid, Relief and Economic Security Act (CARES Act) providing our grantee community with resources to conduct COVID-19 related research. For grantees who have received COVID-19 supplements on existing awards, or who are exercising administrative flexibilities to complete their COVID research, we encourage that these recipients track these expenditures separately from those incurred under the normal scope of their award. The government-wide audit and oversight community, as well as NSF, are committed to sound stewardship of these funds. As such, maintaining strong internal controls over COVID-19 funding will provide a foundation for potential future reporting requirements for NSF and its research community.
  • Awardees should continue to exercise strong internal controls and continue to practice effective financial stewardship under the pandemic environment. NSF will continue to process payments without interruption. Your assigned grant accountant can provide assistance as needed on any questions.
  • Finally, NSF is distributing regular notices regarding cancelling appropriations on existing awards. Per federal appropriation law, the funds listed in these notices will no longer be available for drawdown after September 30, 2020. We strongly encourage financial managers and principal investigators to monitor these balances on their awards to ensure the funding is not lost at fiscal year-end. Awardees are cautioned against advancing remaining funds simply to expend remaining balances, and as always, excess funds drawn should be returned to NSF as soon as practicable.

Department of Energy and Office of Science

A list of all FOAs and DOE Laboratory Announcements may be found at, and, respectively.

See letter from DOE and SC for COVID-19 FAQs.

Non-Department-Funded Work (e.g., Strategic Partnership Project activities); guidance to National Laboratories, NNSA Plants, and other Contractors

National Institutes of Health

The NIH is deeply concerned for the health and safety of people involved in NIH research, and about the effects on the biomedical enterprise in the areas affected by the HHS declared public health emergency for COVID-19. Due to the potential exceptional impact, we want to assure our recipient community that NIH will be doing our part to help you continue your research. For NIH FAQs go to

NIH Notice on Late Submissions
General Frequently Asked Questions (FAQs) – Proposal Submission and Award Management Related to COVID-19
NIH Late Application Policy Due to Public Health Emergency for United States for 2019 Novel Coronavirus (COVID-19)

National Institute of Allergy and Infectious Diseases (NIAID)
Coronaviruses: Information for Researchers
Multi-Pronged Response to the COVID-2019 Outbreak

National Aeronautics and Space Administration

Assistant Administrator for Procurement Message on the Coronavirus

Department of Health and Human Services
Letter to DHS Contractors Regarding COVID-19

Federal Bureau of Investigation
Memo (5/13/2020) – People’s Republic of China (PRC) Targeting COVID-19 Research Organizations

Mississippi Arts Commission

MAC has developed a COVID-19 specific Grant Change Form (attached). Please, complete this form as soon as possible if your grant activity has been impacted by the coronavirus outbreak. Include any current plans to change or postpone grant activities as well as any proposal for alternative disbursement of your grant funds contingent on MAC approval. Submit the form to Arts Industry Director, Kristen Brandt at If you are unable to submit via email, mail your form to 501 North West Street Suite 1101A, Jackson, MS 39201.

SPECIAL NOTE: Laboratory Work

If laboratory work is necessary during this time, please aggressively follow best practices of personal protection.  You no doubt have safety measures already in place for your team.  If lab work is absolutely necessary consider working in shifts, having personal space of six feet, and allowing no more than two / three people at a time in a laboratory of 100 square feet. Please follow CDC and MSDH recommendations.

Laboratory Safety Resources:

Getting Back to the Lab – Lab Safety

Lab Safety Videos List – Videos

Laboratory Safety  – Training Modules

UC Riverside Handwashing Video

Who to Contact:

Technology Transfer, Post-Award Issues, Subawards/Contracts, Research Approval Queues

–  Almesha L. Campbell, Ph.D. – or 601-979-6347

Proposal Submission (including budget review and approval) and Pre-Award Issues

–  Michael Gates, Ph.D. –

IACUC, Financial Conflict of Interest, and Export Control 

– Michael Early –

Human Subjects Research/IRB 

– Christopher Lane – and

Biosafety, HAZMAT, and Radiation Safety

– LaShinda Washington –

General Policy Concerns and Signature Authority

Joseph A. Whittaker, Ph.D. (VP) / cc.

In emergency cases, please call Tel: 601-979-6347 (Almesha L. Campbell, Ph.D.)


IACACU Contingency Plan


Office of Laboratory Animal Welfare (OLAW) Disaster Planning and Response Resources:

IRB Contingency Plan


PRIM&R: COVID-19 and Coronavirus: Updates for the Oversight Community:


Forms and Applications

For forms and applications, documents, policies and procedures, Indirect Cost Rate Agreement, Fringe Benefit Rate Agreement etc –

Additional Resources